Form 8-K - Current report:
SEC Accession No. 0001181431-12-019767
Filing Date
2012-03-28
Accepted
2012-03-27 18:13:09
Documents
2
Period of Report
2012-03-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rrd340037.htm 8-K 12989
2 DYNAVAX REPORTS FINAL PHASE 3 DATA FOR HEPLISAV IN CKD PATIENTS AND NEW DATA FRO rrd340037_37435.htm EX-99 9714
  Complete submission text file 0001181431-12-019767.txt   23804
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 12718188
SIC: 2834 Pharmaceutical Preparations